Yea Christopher
SEC insider (Form 3/4/5 filer). CIK 0001691102. CHIEF DEVELOPMENT OFFICER at KalVista Pharmaceuticals, Inc. (KALV). 43 reported Form 4/5 transactions since Sep 2024; latest on Jun 11, 2026. Located in FRAMINGHAM, MA.
Companies Yea Christopher has filed insider reports for
- KalVista Pharmaceuticals, Inc. (KALV): Officer, CHIEF DEVELOPMENT OFFICER
Yea Christopher
CIK: 0001691102
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
KalVista Pharmaceuticals, Inc.
Discretionary Trading P&L
Holdings
Transaction History (43 total)
- Jun 11, 2026KALV
KalVista Pharmaceuticals, Inc.
DispositionDirect229.9K shares- - May 27, 2026KALV
KalVista Pharmaceuticals, Inc.
SaleDirect33.8K shares at avg. $26.78$905K - May 27, 2026KALV
KalVista Pharmaceuticals, Inc.
ExerciseDirect33.8K shares at avg. $7.07$239K - May 26, 2026KALV
KalVista Pharmaceuticals, Inc.
SaleDirect2K shares at avg. $26.78$53K - May 22, 2026KALV
KalVista Pharmaceuticals, Inc.
ExerciseDirect3.1K shares- - May 22, 2026KALV
KalVista Pharmaceuticals, Inc.
SaleDirect2.4K shares at avg. $26.78$63K - May 21, 2026KALV
KalVista Pharmaceuticals, Inc.
ExerciseDirect3.8K shares- - May 18, 2026KALV
KalVista Pharmaceuticals, Inc.
SaleDirect1.1K shares at avg. $26.76$30K - May 17, 2026KALV
KalVista Pharmaceuticals, Inc.
ExerciseDirect1.8K shares- - Feb 23, 2026KALV
KalVista Pharmaceuticals, Inc.
SaleDirect4.3K shares at avg. $15.57$68K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 11, 2026 | KALV KalVista Pharmaceuticals, Inc. | Disposition | 229,918 | - | $0 | Direct |
| May 27, 2026 | KALV KalVista Pharmaceuticals, Inc. | Sale | 33,800 | $26.78 | $905,225 | Direct |
| May 27, 2026 | KALV KalVista Pharmaceuticals, Inc. | Exercise | 33,800 | $7.07 | $238,966 | Direct |
| May 26, 2026 | KALV KalVista Pharmaceuticals, Inc. | Sale | 1,966 | $26.78 | $52,645 | Direct |
| May 22, 2026 | KALV KalVista Pharmaceuticals, Inc. | Exercise | 3,125 | - | $0 | Direct |
| May 22, 2026 | KALV KalVista Pharmaceuticals, Inc. | Sale | 2,358 | $26.78 | $63,158 | Direct |
| May 21, 2026 | KALV KalVista Pharmaceuticals, Inc. | Exercise | 3,750 | - | $0 | Direct |
| May 18, 2026 | KALV KalVista Pharmaceuticals, Inc. | Sale | 1,108 | $26.76 | $29,650 | Direct |
| May 17, 2026 | KALV KalVista Pharmaceuticals, Inc. | Exercise | 1,774 | - | $0 | Direct |
| Feb 23, 2026 | KALV KalVista Pharmaceuticals, Inc. | Sale | 4,347 | $15.57 | $67,669 | Direct |
1-10 of 43 transactions